Recombinant Human Hyaluronidase (HYSORPTASE®)

Recombinant Human Hyaluronidase (HYSORPTASE®) is a mammalian cell-expressed recombinant human hyaluronidase (rHuPH20) that locally degrades subcutaneous hyaluronic acid to temporarily clear the way for fluid flow, allowing large-volume drugs (up to 200 mL) to be given subcutaneously beyond the usual 2 mL limit, improving patient experience and the efficiency of drug administration. Manufactured directly by Shanghai LePure Biotech Co., Ltd. at industrial grade and certified to Chinese Pharmacopoeia (ChP) standards, it is distributed across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.